#glp-3-agonists
#glp-3-agonists

Alternative medicine

Understanding and Navigating Weight Loss Medications

fromAlternative Medicine Magazine

Wellness

GLP-1s and the Thin Ideal

Alternative medicine

What is GLP-1?

Health

New study of 77,000 patients reveals the hard truth about GLP1s

GLP-1 medications produce temporary weight loss; stopping treatment causes weight regain and return of metabolic complications within 1-2 years.

Public health

fromInsideHook

Research Suggests GLP-1 Drugs Could Be for the Long Haul

People using GLP-1 weight-loss medications often require long-term or lifelong treatment because stopping them commonly leads to rapid weight regain and lost metabolic benefits.

1 day ago

The Dangerous Allure of Compounded GLP-1 Drugs

Compounded GLP-1 medications can be unsafe and unregulated, leading to serious health risks like acute liver failure.

Alternative medicine

Understanding and Navigating Weight Loss Medications

GLP-1 and semaglutide medications effectively reduce obesity but require medical guidance and are not standalone solutions to weight management.

Wellness

fromAlternative Medicine Magazine

GLP-1s and the Thin Ideal

GLP-1 medications in a culture equating thinness with worth risk reinforcing body surveillance, masking eating disorders, and creating harmful weight cycling patterns with psychological consequences.

Alternative medicine

What is GLP-1?

Health

New study of 77,000 patients reveals the hard truth about GLP1s

fromInsideHook

Public health

Research Suggests GLP-1 Drugs Could Be for the Long Haul

more#glp-1-medications

23 hours ago

Gen Z wants their job to cover GLP-1 weight-loss drugs, survey suggests

A new ZipHealth survey of over 1,000 workers found that nearly half (47%) of Gen Z said GLP-1 coverage would affect their choices between two similar jobs.

Healthcare

The FDA approves a new obesity pill, giving patients another option

We've created a small molecule chemical which gets in your body very well. It can mimic the effects of the peptide and can be taken more conveniently any time of day without any food or water restrictions.

US news

1 day ago

Is a new weight-loss drug making people fall out of love?

Retatrutide, an experimental weight-loss drug, may cause emotional flattening and affect relationships by dampening the brain's reward system.

What Weight-Loss Drugs Reveal About How We Judge Effort

Visible struggle in weight loss is often misinterpreted as greater effort, while underlying biological and psychological factors play a significant role.

fromABC7 New York

Medicine

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

Medicine

US approves new oral weight-loss pill developed by Eli Lilly

Psychology

1 week ago

What Weight-Loss Drugs Reveal About How We Judge Effort

Visible struggle in weight loss is often misinterpreted as greater effort, while underlying biological and psychological factors play a significant role.

fromABC7 New York

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

Eli Lilly's orforglipron, branded as Foundayo, is a new FDA-approved weight-loss pill expected to be available soon.

US approves new oral weight-loss pill developed by Eli Lilly

FDA approved orforglipron, a new oral weight-loss medication by Eli Lilly, offering an alternative to injectable GLP-1 treatments.

SF food

What does a 'GLP-1 Friendly' diet look like? We asked nutritionists

3 days ago

Medicine

A 59-year-old man lost 25 pounds on Foundayo, the new GLP-1 weight-loss pill

Medicine

A new weight loss pill is here and it could reshape the GLP-1 market

Medicine

A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals.

from24/7 Wall St.

Medicine

These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target

fromSlate Magazine

Medicine

The Risk Too Many People Are Taking With Ozempic

SF food

What does a 'GLP-1 Friendly' diet look like? We asked nutritionists

Food companies are branding products as 'GLP-1 Friendly' to cater to consumers using obesity and diabetes medications.

3 days ago

A 59-year-old man lost 25 pounds on Foundayo, the new GLP-1 weight-loss pill

Eli Lilly's Foundayo, the first once-daily GLP-1 pill for weight loss, has been approved by the FDA.

Medicine

A new weight loss pill is here and it could reshape the GLP-1 market

A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals.

Eli Lilly's Foundayo, a new weight loss pill, offers flexible dosing and outperforms competitors in weight loss and health metrics.

from24/7 Wall St.

These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target

The GLP-1 revolution is driving biopharma M&A strategies, with companies like Viking Therapeutics and Structure Therapeutics as prime acquisition targets.

fromSlate Magazine

The Risk Too Many People Are Taking With Ozempic

GLP-1 receptor agonists, while effective for obesity and diabetes, may cause significant gastrointestinal issues and other health risks.

Riding the GLP-1 boom, VITL lands $7.5M to overhaul cash-pay clinic prescribing | TechCrunch

VITL provides an e-prescribing platform tailored for cash-pay medical businesses, significantly improving prescription management efficiency for clinics.

#glp-1-drugs

Exercise

Strength persists after a mid-life course of obesity drugs

fromTasting Table

Food & drink

How GLP-1 Is Reshaping Restaurant Menus In 2026 - Tasting Table

Medicine

Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s

fromBusiness Insider

Healthcare

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

Medicine

The GLP-1 saga is only getting juicier and messier

Public health

Are obesity drugs causing a severe complication? What the science says

Exercise

Strength persists after a mid-life course of obesity drugs

fromTasting Table

Food & drink

How GLP-1 Is Reshaping Restaurant Menus In 2026 - Tasting Table

Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s

Stopping GLP-1 drugs can quickly reverse health benefits, increasing cardiovascular risks and leading to weight regain and other health issues.

fromBusiness Insider

Healthcare

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

The GLP-1 saga is only getting juicier and messier

The FDA warned Novo Nordisk about failing to disclose risks and report deaths linked to semaglutide, while GLP-1 drugs surge in popularity for diabetes and weight loss despite unapproved market alternatives.

Public health

Are obesity drugs causing a severe complication? What the science says

more#glp-1-drugs

#fda-approval

4 days ago

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval

Eli Lilly's orforglipron received FDA approval as a weight loss treatment, showing significant weight loss in clinical trials.

Medicine

FDA approves higher-dose version of Wegovy shots

4 days ago

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval

Eli Lilly's orforglipron received FDA approval as a weight loss treatment, showing significant weight loss in clinical trials.

Medicine

FDA approves higher-dose version of Wegovy shots

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.

Medicine

GLP-1 drugs don't work for everyone. But personalized obesity care in the future might

fromWIRED

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.

Medicine

GLP-1 drugs don't work for everyone. But personalized obesity care in the future might

more#obesity

NHS England to offer weight-loss drugs to 1.2m people to reduce risk of heart attacks and strokes

NHS England will provide weight-loss drugs to over 1 million people to reduce heart attack and stroke risks.

fromwww.bbc.com

Weight-loss jabs will be offered on NHS for people at risk of further heart attacks

Wegovy will be provided for free on the NHS to over a million at-risk individuals in England to reduce heart attack and stroke risks.

Artificial intelligence

AI, GLP-1s, and the Fear of Lazy Shortcuts

Tools like GLP-1s and AI are not inherently shortcuts that cause laziness; their impact depends on how users choose to employ them.

fromJezebel

1 week ago

First It Was Mini-Livers; Now Science Can Give You a Bonus Pancreas as Well?

New studies show potential for injectable mini-livers and implantable devices with pancreatic cells to aid liver disease and diabetes management.

Health

These cells in the body remember fat. Here's what that means for weight loss

Fat cells and immune cells retain epigenetic memory of obesity, making weight regain easier even after significant weight loss through any method.

#glp-1-receptor-agonists

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1 receptor agonists, particularly semaglutide and liraglutide, reduce the risk of worsening anxiety and depression in people with diabetes.

Can weight-loss pills replace injectables? What the science says

Oral anti-obesity pills based on GLP-1 receptor agonists are entering the market, offering needle-free alternatives to injectable weight-loss drugs, though they produce less weight loss than injections.

Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds

Wegovy users have nearly five times higher risk of sudden vision loss compared to Ozempic users, with risk appearing dose-dependent and higher in men.

Medicine

Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds

Medicine

Head-to-head trial pitting Eli Lilly's oral GLP-1 against oral semaglutide underscores efficacy of weight-loss pills

Medicine

People Who Go Off GLP-1s Are Experiencing a Sudden and Terrible Hunger

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1 receptor agonists, particularly semaglutide and liraglutide, reduce the risk of worsening anxiety and depression in people with diabetes.

Can weight-loss pills replace injectables? What the science says

Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds

Wegovy users have nearly five times higher risk of sudden vision loss compared to Ozempic users, with risk appearing dose-dependent and higher in men.

Medicine

Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds

Medicine

Head-to-head trial pitting Eli Lilly's oral GLP-1 against oral semaglutide underscores efficacy of weight-loss pills

more#glp-1-receptor-agonists

Medicine

People Who Go Off GLP-1s Are Experiencing a Sudden and Terrible Hunger

Experimental GLP-3 weight loss drug retatrutide shows promising results in clinical trial

Retatrutide, a triple-receptor GLP-3 agonist drug, achieved up to 36.6 pounds of average weight loss and improved blood sugar control in phase 3 clinical trials for type 2 diabetes.

#glp-1-agonists

Environment

GLP-1s Are an Environmental Catastrophe

Medicine

GLP-1 Anti-Obesity Rx and Alcohol and Substance Use Disorders

fromScienceDaily

Medicine

Study raises red flags over long-term effectiveness of popular weight loss drugs like Ozempic

Environment

GLP-1s Are an Environmental Catastrophe

Medicine

GLP-1 Anti-Obesity Rx and Alcohol and Substance Use Disorders

fromScienceDaily

Medicine

Study raises red flags over long-term effectiveness of popular weight loss drugs like Ozempic

GLP-1 draws pharma advertisers to double down on the Super Bowl

Pharmaceutical and healthcare brands are heavily advertising GLP-1 and related products during the Super Bowl despite potential regulatory threats to pharma advertising.

fromBusiness Insider

People are using Ozempic to drink less. We already have FDA-approved drugs for that.

To some extent, Americans are talking about alcohol more than ever. We're having open conversations about the negative health impacts of drinking. People are consuming less booze overall and examining strategies to moderate, even as each drink packs more punch. There is one aspect of alcohol we're still not talking about: addiction, and, more precisely, the medical treatments available to combat it. What's even odder - your doctor may not know much about them, either.

Public health

Healthcare

fromThe Atlantic

GLP-1 Envy Was Just the Beginning

Telehealth companies market paid services that promise wealthy-style, personalized concierge care, highlighting and monetizing the divide between elite proactive care and reactive mainstream care.

Drugs like Ozempic are improving kidney treatment and changing lives

GLP-1 receptor agonists, finerenone, and SGLT2 inhibitors represent breakthrough treatments for chronic kidney disease, with combined therapy potentially adding decades to patients' lives.

Public health

fromBBC

Inside Health - What are the side effects of weight loss drugs? - BBC Sounds

Weight loss drugs were used by over 1.5 million UK adults in 2024–25 and can cause side effects including nausea and painful gallstones.

fromIndependent

Weight-loss jab Wegovy has 'highest risk of rare eye stroke', study finds

Wegovy carries nearly five times higher risk of eye stroke and sudden sight loss compared to Ozempic, with men facing three times greater risk than women.

Public health

fromwww.bbc.com

Could weight-loss jabs be behind rising gallbladder removals?

Specialist doctors call for more research into a possible link between GLP-1 weight-loss injections and rising gallbladder removals and gallstones.